Patent applications and USPTO patent grants for MCCABE; James.The latest application filed is for "compounds and methods for inhibiting jak".
Patent | Date |
---|---|
Compounds And Methods For Inhibiting Jak App 20220119372 - ASTRAND; Annika Birgitta Margareta ;   et al. | 2022-04-21 |
Compounds and methods for inhibiting JAK Grant 11,247,983 - Astrand , et al. February 15, 2 | 2022-02-15 |
Salts of IJAK inhibitors and methods of using the same Grant 11,149,029 - Pettersen , et al. October 19, 2 | 2021-10-19 |
Compounds And Methods For Inhibiting Jak App 20210078981 - ASTRAND; Annika Birgitta Margareta ;   et al. | 2021-03-18 |
Compounds and methods for inhibiting JAK Grant 10,654,835 - Astrand , et al. | 2020-05-19 |
Novel Salts Of Ijak Inhibitors And Methods Of Using The Same App 20200062737 - PETTERSEN; Anna Matilda Angelica ;   et al. | 2020-02-27 |
Maleate Salts Of A Quinazoline Derivative Useful As An Antiangiogenic Agent App 20190375730 - MCCABE; James | 2019-12-12 |
Compounds And Methods For Inhibiting Jak App 20190092760 - ASTRAND; Annika ;   et al. | 2019-03-28 |
Compounds and methods for inhibiting JAK Grant 10,167,276 - Astrand , et al. J | 2019-01-01 |
Maleate Salts Of A Quinazoline Derivative Useful As An Antiangiogenic Agent App 20180170913 - MCCABE; James | 2018-06-21 |
Maleate salts of a quinazoline derivative useful as an antiangiogenic agent Grant 9,890,140 - McCabe February 13, 2 | 2018-02-13 |
Compounds And Methods For Inhibiting Jak App 20170320857 - ASTRAND; Annika ;   et al. | 2017-11-09 |
Compounds And Methods For Inhibiting Jak App 20170088543 - ASTRAND; Annika ;   et al. | 2017-03-30 |
Maleate salts of a quinazoline derivative useful as an antiangiogenic agent Grant 9,556,151 - McCabe January 31, 2 | 2017-01-31 |
Maleate Salts Of A Quinazoline Derivative Useful As An Antiangiogenic Agent App 20170000791 - MCCABE; James | 2017-01-05 |
Maleate Salts of a Quinazoline Derivative Useful as an Antiangiogenic Agent App 20150025091 - MCCABE; James | 2015-01-22 |
Maleate salts of a quinazoline derivative useful as an antiangiogenic agent Grant 8,859,570 - McCabe October 14, 2 | 2014-10-14 |
Maleate Salts Of A Quinazoline Derivative Useful As An Antiangiogenic Agent App 20100298357 - MCCABE; James | 2010-11-25 |
Novel Crystalline Compound Useful As Glk Activator App 20100094009 - McCabe; James ;   et al. | 2010-04-15 |
Crystalline compound Grant 7,696,191 - McCabe , et al. April 13, 2 | 2010-04-13 |
Novel Crystalline Compound App 20080153800 - MCCABE; James ;   et al. | 2008-06-26 |
Maleate salts of a quinazoline derivative useful as an antiangiogenic agent App 20070129387 - McCabe; James | 2007-06-07 |
Quinazoline derivatives App 20070099943 - Bradbury; Robert Hugh ;   et al. | 2007-05-03 |
Quinazoline derivatives Grant 7,148,230 - Bradbury , et al. December 12, 2 | 2006-12-12 |
Quinazoline derivatives App 20050165035 - Bradbury, Robert Hugh ;   et al. | 2005-07-28 |
SEC | 0001222724 | MCCABE JAMES |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.